AXISCADES Technologies Ltd

- No immediate equity fundraising planned for the listed entity; any strategic investment is likely to come through a Special Purpose Vehicle (SPV) holding Bangalore land. (Page 10) - Discussions are ongoing with strategic partners (major OEM customers) about funding for new facilities, but no committed figures are available yet. (Page 6) - The company aims to minimize debt, planning only bridge finance, not exceeding Rs. 50 crores, pending strategic investments. (Page 8, Page 10) - Debt level is currently manageable with Rs.163 crores gross debt and Rs.50 crores net debt; no significant increase expected if strategic investments materialize. (Page 8) - Non-core asset divestments are planned to generate cash for funding CAPEX and reduce the need for borrowing. (Pages 6, 8) - Overall, funding for expansion and CAPEX (~Rs.1,500 crores over 3 years) will come from internal accruals, strategic investments, and minimal bridge debt. (Pages 6, 10)

- AXISCADES plans phased capital investment totaling approximately Rs.1,500 crores over three years, including Hyderabad facility. - Phase-I CAPEX is around Rs.150-180 crores for FY26, for Bangalore facility and related infrastructure. - Phase-II CAPEX will be about Rs.450 crores, with remaining CAPEX in Phase-III. - Funds expected from divestment of non-core assets, internal accruals, and strategic investments from foreign OEMs. - Management aims to minimize debt, with any borrowing likely limited to bridge financing not exceeding Rs.50 crores in FY26. - Strategic investment discussions are ongoing, possibly to occur in Q1 FY27, likely through an SPV holding facility land; no equity dilution planned in the listed entity currently. - Missile Atmanirbhar Complex in Hyderabad and Devanahalli Atmanirbhar Complex ongoing with additional investment plans.

- AXISCADES targets over 40% annual growth in core businesses (aerospace, defense, ESAI) for FY26 and FY27, with further acceleration as new facilities become operational. - Confident to achieve FY26 guidance in revenue and profitability, supported by a strong order book and strategic alliances. - Defense revenues grew 37% YoY in Q2 and 31% in H1; aerospace grew 16% in Q2 and 12% in H1. - Mistral EMS facility coming online by March 2026 expected to generate $8-10 million revenue in FY27. - Anticipated growth from hyperscaler clients, expecting to scale from $2 million this year to $6-7 million next year if facilities are ready. - Robust outlook for LLTR order by January 2026; QRSAM segment revenue expected mainly from FY27 onwards. - Aim to reach $1 billion (Rs. 9,000 crores) revenue by 2030, driven by phased CAPEX and facility expansion. - Continued focus on converting 60% of pipeline into confirmed orders with strong visibility through 2028-2030.

- AXISCADES targets over 40% year-on-year growth in core businesses for FY26 and FY27, with acceleration to over 70% growth projected for FY28-30 as new facilities come online (Page 4, Page 5). - FY26 core segment revenue expected to grow by approximately 45%, with overall EBITDA also growing about 45% (Page 17). - Core verticals such as aerospace, defense, and ESAI are expected to maintain robust growth and margin expansion (Page 5). - The company aims to improve per capita EBITDA by 30% in FY26 (Page 4). - Non-annualized diluted EPS for H1 FY26 was Rs.10.21, up 53% YoY, indicating strong earnings growth momentum (Page 5). - Long-term goal is to reach Rs.9,000 crores revenue by 2030, supported by investments and strategic partnerships (Page 4, Page 10).

- Pipeline orders: Approximately Rs.12,000 crores were expected to convert into confirmed orders; conversion is ongoing and being actively worked on (Page 16). - QRSAM segment: Expecting around seven systems in the next two months, with production orders anticipated by March 2026, contributing revenue from FY27 (Page 17). - LLTR order: Awaiting negotiation with Bharat Electronics, expected order by January (Page 19). - Defense segment: Strong visibility for FY27, FY28, FY29, and FY30 with comfortable order book and growth trajectory (Page 17). - Emergency procurement orders for man-portable counter-drone systems already received; more trials ongoing (Page 12). - MBDA test benches: Supply ongoing with plans to deliver around 10 benches per year (Page 13). - BrahMos seeker: Trials expected to complete by March, with orders potentially starting next year (Page 13).